Pliva

Name

Pliva

Legal name

Pliva

Website

https://pliva.com

Company type

Private

Founded year

1921

Operating status

Operating

Headcount range

11–50 employees

Short description

Pliva is a Croatian generic and biopharmaceutical manufacturer founded in 1921 and wholly-owned by Teva Pharmaceutical Industries, distributing prescription and OTC medicines to patients, healthcare professionals, and institutions across Croatia and Southeast Europe via hospital procurement systems and retail pharmacy networks.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Biological Product (except Diagnostic) Manufacturing (325414), Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Generic Finished Dosage Form (FDF) Manufacturing (HLAIABAH)

akta.pro secondary industries

Generic Hospital & Institutional Products (HLAIABAL), Generic Tender & Government Supply Markets (HLAIABAM)

Keywords

• Generic pharmaceuticals
• Prescription medications
• Over-the-counter medicines
• Biopharmaceutical products
• Pharmaceutical manufacturing

Headquarters

HQ city

Zagreb

HQ country

Croatia

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. Generic Pharmaceutical Sales: Pliva generates revenue through the sale of generic prescription medicines and over-the-counter (OTC) products. The company develops and manufactures generic drugs that treat infections, manage chronic conditions, and improve overall health outcomes for patients globally.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

Pliva develops, manufactures, and distributes generic prescription medicines (Naši lijekovi) and over-the-counter pharmaceutical products (Bezreceptni proizvodi) in Croatia and Southeast Europe as part of Teva Pharmaceutical Industries' portfolio. The company focuses on making quality generic and biopharmaceutical medicines accessible and affordable for patients, serving approximately 200 million people globally through Teva's network.

Product overview

Pliva is a Croatian pharmaceutical company operating as part of Teva Pharmaceuticals, focused on generic and biopharmaceutical medications. The company offers prescription medicines (Naši lijekovi) and over-the-counter products (Bezreceptni proizvodi), serving approximately 200 million people globally with daily medication use. Supporting platforms include PLIVAzdravlje for citizen health education and PLIVAmed.net for healthcare professional resources, along with the PhEA mobile application for pharmaceutical events. The product portfolio centers on making quality generic medicines accessible across Croatia and the Southeast Europe region.

Differentiator

Problem solved

Functional benefit

Products and services

• Naši lijekovi (Our Medicines) Prescription pharmaceutical medications for treating various medical conditions, part of Teva's global generic and biopharmaceutical portfolio. Available through pharmacies and hospitals in Croatia and Southeast Europe.
• Bezreceptni proizvodi (Over-the-Counter Products) Non-prescription medications available directly to consumers through retail pharmacy networks for self-medication of minor ailments.
• PLIVAzdravlje Citizen-facing health information platform providing educational content about health conditions, medications, and wellness for patients and the general public.
• PLIVAmed.net Portal for healthcare professionals offering medical information, professional resources, and product content for doctors, pharmacists, and medical staff.
• PhEA - Pharma Event App Mobile application supporting pharmaceutical events with information, networking, and event resources for healthcare professionals.

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• TevacoreStrategic or Co-development PartnerPliva is a wholly-owned subsidiary of Teva Pharmaceutical Industries, one of the world's largest generic pharmaceutical companies. The partnership provides Pliva with global scale, R&D capabilities, and access to a portfolio of generic and biopharmaceutical products. Pliva represents Teva's operations in Croatia and Southeast Europe.

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Stada Arzneimittel: German-based European generics and consumer healthcare company. Comparable to Pliva in providing generics, specialty pharma, and OTC products across European markets with a portfolio-led approach to multiple therapeutic categories.
• Krka: Slovenia-based generic pharmaceutical company with a strong Central and Southeast European footprint, offering prescription generics, OTC products, and animal health. Directly comparable to Pliva in regional generics leadership, multi-country CEE/SEE distribution, and integrated manufacturing model.
• Sandoz: Novartis's recently spun-off global generics and biosimilars division, one of the world's largest. Highly comparable as a broad-spectrum generic and biosimilar player with global pipeline depth, operating across European markets where Pliva also competes.
• Viatris: Global generics and specialty pharmaceutical company formed from Mylan and Upjohn. Comparable to Pliva in offering a broad portfolio of off-patent prescription and OTC medicines across multiple European markets, with scale-based cost advantages.
• Zentiva: Czech-headquartered European generics company with strong CEE/SEE presence. Closely comparable to Pliva in regional generics focus, branded-generic positioning, and distribution model across Central and Southeast European markets.

Emerging players

• Hikma Pharmaceuticals: UK-headquartered multinational generics and injectables company expanding its European branded-generics footprint. Comparable to Pliva in offering branded and unbranded generics across multiple therapeutic categories with European distribution.

Regional players

• Alkaloid: North Macedonia-based pharmaceutical manufacturer with regional SEE distribution. Comparable to Pliva in regional generic pharma manufacturing, hospital channel presence, and SEE market coverage in overlapping geographies.
• Alvogen: US-headquartered but with significant Central and Eastern European operations and a generics-plus-brand portfolio. Comparable to Pliva in CEE/SEE generic market presence and portfolio breadth across therapeutic areas.
• Gedeon Richter: Hungarian-headquartered pharmaceutical company with strong CEE presence in branded generics and original research. Comparable to Pliva as a regional Central European pharma champion with hospital-channel distribution and chronic disease portfolio focus.

Broad incumbents

• Teva Pharmaceutical Industries: Pliva's parent company and the world's largest generic pharmaceutical manufacturer. Relevant as both the corporate parent and the broadest incumbent in the global generics category that defines Pliva's competitive context and pipeline.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/pliva_hrvatska
• Facebookfacebook.com/plivazdravlje
• LinkedInlinkedin.com/company/pliva

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pliva